National and Kapodistrian University of Athens
Μελέτη μορίων που εμπλέκονται στα μονοπάτια σηματοδότησης PI3K/AKT/mTOR και RAS/RAF/MEK/ERK σε αστροκυτώματα
Abstract
dc:descriptionAstrocytomas the most common type of primary brain tumour represent a spectrum of tumours of various differentiation Glioblastomas (GBMs) in particular are notorious for their rapid growth and dismal prognosis despite multidisciplinary therapeutic approaches Dissecting the signal transduction pathways is imperative for the development of more rational biologic treatment strategies allowing the targetting of specific steps in the transduction cascade for therapeutic purposes Two of the most important signalling cascades frequently dysregulated in cancer are the Ras/Raf/MEK/ERK (MAPK) and the PI3K/AKT/mTOR pathways The Ras/RAF/MEK/ERK intracellular signal transduction pathway is a highly conserved module that is involved in various cellular functions including cell proliferation, differentiation and migration It is activated m response to many different signals andis organized as a cascade in which RAF proteins are activated in a Ras dependent manner Once recruited to the membrane and activated by Ras RAF phosphorylates and activates MEK1/2 which in turn phosphorylates and activates the effector MAP kinases ERK1 and ERK2 Upon activation ERK1/2 can phosphorylate over 100 possible substrates with diverse functions such as membrane cytoplasmic cytoskeletal nbosomal and nuclear proteins (transcription factors) that can influencecell fate The PI3K/AKT/mTOR signalling pathway plays a complex role in cell biology metabolism and in the regulation of cell growth and death Activation of PI3K can occur through tyrosine kinase growth factor receptors such as epidermal growth factor receptor (EGFR) and insulin like growth factor 1 receptor (IGF IR) cell adhesion molecules such as integrins G protein-coupled receptors (GPCRs) and oncogenes such as Ras PI3K phosphorylates PIP2 to PIP3 which activates downstream effector molecules such as AKT AKT functions through its ability to phosphorylate a number of key pro oncogenic targets that promote cell growth or inhibit apoptotic pathways and directly phosphorylates and inhibits TSC1 and TSC2 which in turn activate mTOR and downstream targets mTOR is a central regulator of protein synthesis cell ρ rohferation cell cycle progression and cell survival The mTORCl pathway regulates cell growth through its downstream effectors such as theregulators of translation 4EBP1 and p70S6Kl The current investigation focuses on the presence of mutations in the PIK3CA gene We also examined the expression of pERK ρΑΚΤ ρ mTOR and ρ p70S6K in diffusely infiltrating astrocytomas This is a study of 155 diffusely infiltrating astrocytomas Polymerase chain reaction single strand confirmation polymorphism (PCR SSCP) and sequencing analysis were used for PIK3CA gene mutation detection pERK pAKT p-mTOR and ρ p70S6Kexpression were examined by immunohistochemistry Statistical analysis was performed Mutational analysis identified mutations in exon 9 in two out of 52 cases (3%) of glioblastomas whereas no mutations were found in exon 20 of PIK3CA gene Neither diffuse astrocytomas nor anaplastic astrocytomas revealed any mutations in these exons of PIK3CA gene Nuclear and cytoplasmic ρ ERK immunoreactivity was displayed in 98 8% and 73 3% of cases respectively wher eas nuclear andcytoplasmic ρ AKT immunoreactivity was displayed in 93 05% and 59 7% of cases respectively ρ ERK and ρ AKT nuclear expression was positively correlated with ρ ERK and ρ AKT cytoplasmic expression respectively Moreover nuclear and cytoplasmic ρ ERK expression and ρ AKT cytoplasmic expression were positively correlated with VEGF ρ ERK nuclear expression also correlated with microvascular characteristics ρ mTOR expression was mainly cytoplasmic and was observed in 84 6% of cases whereas ρ p70S6K expression was mainly nuclear and was observed in all of cases pmTOR cytoplasmic expression was positively correlated with p-p70S6K nuclear expression Moreover ρ mTOR expression increased in parallel with tumour grade whereas ρ p70S6K expression was marginaly correlated with patients age Multivariate analysis selected ρ ERK nuclear and p-AKT cytoplasmic expression as significant prognosticators of patients survival Our study reports the low frequency of PIK3CA mutations in astrocytomas despite the presence of activated AKT proteins Moreover the correlation of ρ ERK ρ AKT ρ mTOR and p-p70S6K expression with patients survival and standard chmcopathological features suggests the possible crucial role of the activation ofthese proteins in human ghomagenesis In conclusion PI3K/AKT/mTOR and RAS/RAF/MERK/ERK pathways cooperate to promote ghomagenesis and encourage prospective investigations to validate their role as therapeutic targets.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ελ-Χαμπέρ, Ηλίας
Subjects
dc:subject × 27- Γλοιώματα
- Αστροκυτώματα
- Ανοσοϊστοχημεία
- Στατιστική ανάλυση
- Μεταλλαγές PIK3CA
- Έκφραση p-ERK
- Έκφραση p-AKT
- Έκφραση p-mTOR
- Έκφραση p-p70S6K
- Κλινικοπαθολογοανατομικά χαρακτηριστικά
- Επιβίωση ασθενών
- Gliomas
- Astrocytomas
- PCR-SSCP
- Immunohistochemistry ( IHC)
- Statistical analysis
- PIK3CA mutations
- p-ERK expression
- p-AKT expression
- p-mTOR expression
- p-p70S6K expression
- Clinocopathological features
- Patients' survival
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25422